A detailed history of Parthenon LLC transactions in Pfizer Inc stock. As of the latest transaction made, Parthenon LLC holds 100,152 shares of PFE stock, worth $2.97 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
100,152
Previous 105,365 4.95%
Holding current value
$2.97 Million
Previous $2.92 Million 4.14%
% of portfolio
0.36%
Previous 0.38%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $131,680 - $154,304
-5,213 Reduced 4.95%
100,152 $2.8 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $20,271 - $23,278
783 Added 0.75%
105,365 $2.92 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $5,043 - $6,550
-193 Reduced 0.18%
104,582 $3.01 Million
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $81,444 - $95,200
-2,538 Reduced 2.37%
104,775 $3.48 Million
Q1 2023

May 08, 2023

SELL
$39.39 - $51.28 $87,839 - $114,354
-2,230 Reduced 2.04%
107,313 $4.38 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $27,555 - $35,970
-660 Reduced 0.6%
109,543 $5.62 Million
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $11,115 - $13,568
-254 Reduced 0.23%
110,203 $4.82 Million
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $30,663 - $36,357
-659 Reduced 0.59%
110,457 $5.79 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $91,500 - $113,380
-2,000 Reduced 1.77%
111,116 $5.75 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $9,007 - $13,352
-218 Reduced 0.19%
113,116 $6.68 Million
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $186,830 - $239,999
-4,760 Reduced 4.03%
113,334 $4.87 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $170,931 - $193,636
4,760 Added 4.2%
118,094 $4.63 Million
Q1 2021

Apr 23, 2021

BUY
$33.49 - $37.77 $38,647 - $43,586
1,154 Added 1.03%
113,334 $4.11 Million
Q4 2020

Feb 03, 2021

SELL
$33.47 - $42.56 $41,636 - $52,944
-1,244 Reduced 1.1%
112,180 $4.13 Million
Q3 2020

Oct 29, 2020

SELL
$31.75 - $37.25 $12,700 - $14,900
-400 Reduced 0.35%
113,424 $4.16 Million
Q1 2020

Apr 28, 2020

SELL
$27.03 - $38.62 $229,755 - $328,270
-8,500 Reduced 6.95%
113,824 $3.72 Million
Q4 2019

Jan 28, 2020

SELL
$32.92 - $37.36 $7,439 - $8,443
-226 Reduced 0.18%
122,324 $4.79 Million
Q3 2019

Oct 31, 2019

BUY
$32.49 - $42.13 $11,014 - $14,282
339 Added 0.28%
122,550 $4.4 Million
Q2 2019

Jul 29, 2019

BUY
$36.98 - $41.52 $63,568 - $71,372
1,719 Added 1.43%
122,211 $5.29 Million
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $25,462 - $27,974
-679 Reduced 0.56%
120,492 $5.12 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $11,617 - $13,245
-302 Reduced 0.25%
121,171 $5.29 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $114,268 - $138,600
-3,315 Reduced 2.66%
121,473 $5.35 Million
Q2 2018

Aug 02, 2018

SELL
$32.98 - $35.16 $167,076 - $178,120
-5,066 Reduced 3.9%
124,788 $4.53 Million
Q1 2018

May 04, 2018

SELL
$31.91 - $37.02 $29,165 - $33,836
-914 Reduced 0.7%
129,854 $4.61 Million
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $2,960 - $3,140
89 Added 0.07%
130,768 $4.74 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $4.05 Million - $4.46 Million
130,679
130,679 $4.67 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Parthenon LLC Portfolio

Follow Parthenon LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parthenon LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parthenon LLC with notifications on news.